Brief: Lee's Pharmaceutical Sees Unaudited Net Profit Attributable Between Hk$12 Mln & Hk$17 Mln For Six Months
21/08/2023 16:15
Aug 21 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* SEES UNAUDITED NET PROFIT ATTRIBUTABLE OF BETWEEN HK$12
MILLION
AND HK$17 MILLION FOR SIX MONTHS
* EXPECTED DECREASE IN PROFIT DUE TO PRICE CUT OF CERTAIN
PRODUCTS
IN EXCHANGE FOR BEING INCLUDED IN NATIONAL REIMBURSEMENT SCHEME
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lee's Pharmaceutical Holdings
See all newsHong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product sales
Brief: Lee's Pharmaceutical Expects H1 Net Profit Of HK$85 Million-HK$95 Million
Brief: Lee's Pharmaceutical Says Investigational New Drug Application For ADC Project ZK2401 Accepted By NMPA
Brief: Ashlins Pharmaceuticals And Lee's Pharm Announce Exclusive License And Supply Agreement Valued At Up To $31 Million
Brief: Lee's Pharmaceutical Says Entered Licensing Agreement With Ashlins Ocular Pharmaceuticals